Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

Clicks: 363
ID: 116128
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
New so-called immune reconstitution therapies (IRTs) have the potential to induce long-term or even permanent drug-free remission in people with multiple sclerosis (MS). These therapies deplete components of the immune system with the aim of allowing the immune system to renew itself. Haematopoietic …
Reference Key
jd2020natureimmune Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lünemann JD;Ruck T;Muraro PA;Bar-Or A;Wiendl H;;
Journal nature reviews neurology
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/31649335/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't N.I.H. Extramural remission induction / methods immunotherapy / methods pmid:31649335 doi:10.1038/s41582-019-0268-z jan d lünemann tobias ruck heinz wiendl immune reconstitution / immunology* immunotherapy / trends* multiple sclerosis / immunology* multiple sclerosis / therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.